Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes: The diabetes outcomes in veterans study

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1744-1748

  Hoffman, Richard M ^a   Shah, Jayendra H ^b,c   Wendel, Christopher S ^b   Duckworth, William C ^d   Adam, Karen D ^a   Bokhari, Syed U ^d   Dalton, Cheri ^b   Murata, Glen H ^a  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SELF MONITORING; STATISTICAL SIGNIFICANCE; BLOOD; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; EATING; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; RACE; TIME; TREATMENT OUTCOME; UNITED STATES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; EATING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036780030     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1744     Document Type: Article

References (12)

1. American Diabetes Association: Tests of glycemia in diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S80-S82, 2001
2. Harris MI: Health care and health status and outcomes for patients with type 2 dabetes. Diabetes Care 23:754-758, 2000
3. Evaluation report of the Accu-Chek Comfort Curve test strip as a plasma-like test strip. Roche Diagnostics, Indianapolis, IN, 2002
4. Statistica for the Macintosh (software program). Tulsa, OK, StatSoft, 1994
5. Bouma M, Dekker JH, de Sonnaville JJ, van der Does FE, de Vries H, Kriegsman DM, Kostense PJ, Heine RJ, van Eijk JT: How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 22:904-907, 1999
6. Paisey RB, Bradshaw P, Hartog M: Home blood glucose concentrations in maturity-onset diabetes. Br Med J 280:596-598, 1980
7. Gonen B, Rochman H, Rubenstein AH, Tanega SP, Horwitz DL: Haemoglobin Al: an indication of the metabolic control of diabetic patients. Lancet 734-737, 1977
8. Prendergast C, Smyth O, Murray F, Cunningham SK, McKenna TJ: The relationship of blood glucose and haemoglobin Al levels in diabetic subjects. Ir J Med Sci 163:233-235, 1994
9. Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997
10. Soonthornpun S, Rattarasam C, Leelawattana R, Setasuban W: Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 46:23-27, 1999
11. Guillausseau PJ: Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination. Diabet Med 14:798-802, 1997
12. 1c. Diabetes Care 23:1236-1241, 2000